Searched for
LAURUS MEDICINE
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Laurus Labs Q4 Results: Cons PAT increased 19% to Rs 279 crore, revenue rises 5%Laurus Labs reported a 19% year-on-year jump in net profit to Rs 279 crore for the March quarter, with revenue rising 5% to Rs 1,812 crore....
- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...
- Pharma stocks fall up to 4% after Trump says pharma tariffs coming very soonPharma stocks plunged after President Trump announced potential tariffs on imported medicines, impacting Indian drugmakers significantly. I...
- US foreign aid ban hits HIV-related local drug stocksLaurus Labs slumped 11.6%, Aurobindo declined 2%, Cipla fell 1.1% and Strides dropped 5%. Other pharma shares also declined with 19 out of ...
- 3 reasons Laurus Labs is this week's stock pickLaurus Labs will benefit from the growth prospects of the global and domestic pharma indutry as spending on medicines, including Covid-19 v...
- How Laurus Labs capex drive can impact its margins & valuationsRise in headwinds in the pharma industry due to inflation, increase in raw material costs, and excessive competition led to price erosion i...
- Laurus Labs will try to make ‘rare’ drugs affordable in India: CEO“We want to bring the drugs which are not available in India. The biggest factor is affordability. If you bring a medicine which is not aff...
- 19 Indian companies get licence to make Pfizer's oral genericThese include Cipla, Sun Pharma, Laurus Labs, Divi's Laboratories, Glenmark, Emcure, Macleods, SMS Pharmaceuticals, Strides, Torrent, Cadil...
- Laurus Labs inks pact with MPP to produce molnupiravir"We are happy to sign an agreement to manufacture the oral COVID-19 antirviral medication, which is an urgent need of the hour, this is one...
- Midcap pharma regains its vigour on Dalal StreetSo far this week, Nectar Life has gained 36 per cent, Morepen has risen 30 per cent, Panacea has moved up 28 per cent Suven Life has advanc...
- Up 341% YTD, this midcap pharma stock has just got more attractiveKotak Securities said the acquisition of Richmore would be value accretive for the company, though the incoming revenue is small to impact ...
- Q1 net more than annual profit! This API maker is creating a splash on Dalal StreetAPIs are active pharma ingredients used to make drugs, while formulation is the process where APIs are used in specific ratios to produce a...
- Pharma cos don't see supply shortage, oppose exports banGlaxosmithkline India (GSK), one of the largest manufacturers of branded paracetamol in India, said it does not anticipate any supply short...
- Stock market update: Pharma stocks mixed; Granules India surges 5%The BSE Healthcare index was trading 0.49 per cent up at 13,978 around 12:30 pm.
- This company is ready to flood the US with cheap HIV drugsUS patents on key components for some important HIV therapies are poised to expire starting in December and Laurus Labs -- the Hyderabad, I...
- Lauras Labs’ Q2 net up 1% on higher capexFor the quarter ended September 2017, the company posted a 4.3% growth in its revenues to Rs 538.6 crore as against Rs 516.5 crore in the c...
- Cipla, Aurobindo, Emcure to supply HIV drugs for UN-backed programmeAurobindo Pharma Chief Executive Officer said the new licence would help ensure the timely introduction of generic ATV in developing countr...
- Contract drug firm Aptuit to invest $ 100 mnGlobal contract drug development firm Aptuit Inc and Hyderabad-based Laurus Labs Limited on Monday announced the formation of a contract dr...
Load More
